Pergolide

GPTKB entity

Statements (38)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
ergoline derivative
dopamine agonist
gptkbp:approvedBy 1988 (US)
gptkbp:ATCCode N04BC02
gptkbp:brand Permax
Prascend
gptkbp:CASNumber 66104-23-2
gptkbp:contraindication cardiac valvulopathy
gptkbp:discoveredBy gptkb:Eli_Lilly_and_Company
gptkbp:eliminationHalfLife 27 hours
gptkbp:excretion urine
gptkbp:hasMolecularFormula C19H26N2S
gptkbp:hasSMILES CN(C)CCCN1C2=CC=CC=C2C3=C1C=CC(=C3)SCC
https://www.w3.org/2000/01/rdf-schema#label Pergolide
gptkbp:legalStatus withdrawn in US and EU
gptkbp:mechanismOfAction dopamine receptor agonist
gptkbp:metabolism hepatic
gptkbp:molecularWeight 314.49 g/mol
gptkbp:pregnancyCategory Not recommended
gptkbp:PubChem_CID gptkb:CHEMBL1423
47807
43513
gptkbp:routeOfAdministration oral
gptkbp:sideEffect fibrosis
valvular heart disease
gptkbp:synonym Pergolida
Pergolide mesylate
gptkbp:UNII QX9Y1J6CZ1
gptkbp:usedFor gptkb:Parkinson's_disease
equine Cushing's disease
pituitary pars intermedia dysfunction in horses
gptkbp:usedInVeterinaryMedicine yes
gptkbp:withdrawn gptkb:European_Union
gptkb:United_States
2007
gptkbp:bfsParent gptkb:N04BB
gptkbp:bfsLayer 8